Price (delayed)
$8.75
Market cap
$90.95M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$19.41
Enterprise value
$9.05M
Cerecor is a biopharmaceutical company focused on becoming a leader in the development and commercialization of treatments for rare and orphan diseases. The company is advancing its clinical-stage pipeline of
There are no recent dividends present for AVTX.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified. Data from and Sharadar.